Acadian Asset Management’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.65M | Buy |
569,083
+326,976
| +135% | +$2.09M | 0.01% | 664 |
|
|
2025
Q1 | $855K | Sell |
242,107
-369,819
| -60% | -$1.31M | ﹤0.01% | 970 |
|
|
2024
Q4 | $2.31M | Sell |
611,926
-1,158,271
| -65% | -$4.37M | 0.01% | 730 |
|
|
2024
Q3 | $5.73M | Buy |
1,770,197
+558,580
| +46% | +$1.81M | 0.02% | 470 |
|
|
2024
Q2 | $2.3M | Buy |
+1,211,617
| New | +$2.3M | 0.01% | 714 |
|